Position history for BAKER BROS. ADVISORS LP's holdings in ACADIA PHARMACEUTICALS INC
BAKER BROS. ADVISORS LP holds 42.9M shares of ACAD (ACADIA PHARMACEUTICALS INC), worth $954.9M as of 2026-Q1. ACAD represents 5.5% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$954.9M
Current Shares
42.9M
Total Value Change
+$258.1M
Total Shares Change
+18,774
Other major holders of ACAD: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 42.9M |
0.0% |
| $954.9M |
| 5.5% |
| $22.50 |
0 |
| 2025-Q4 | Unchanged | 42.9M | 0.0% | $1.1B | 6.7% | $26.70 | 0 |
| 2025-Q3 | Unchanged | 42.9M | 0.0% | $915.4M | 6.6% | $21.32 | 0 |
| 2025-Q2 | Increased | 42.9M | +0.0% | $925.3M | 9.0% | $22.12 | 62 |
| 2025-Q1 | Unchanged | 42.9M | 0.0% | $712.2M | 7.9% | $17.07 | 0 |
| 2024-Q4 | Unchanged | 42.9M | 0.0% | $786.8M | 8.4% | $16.69 | 0 |
| 2024-Q3 | Unchanged | 42.9M | 0.0% | $659.5M | 6.8% | $15.69 | 0 |
| 2024-Q2 | Increased | 42.9M | +0.0% | $696.8M | 8.9% | $16.25 | 61 |